Skip to content
2000
Volume 11, Issue 1
  • ISSN: 2667-3371
  • E-ISSN: 2667-338X

Abstract

The Electronic Common Technical Document (eCTD) has streamlined regulatory submissions by offering a standardized format that improves communication and reduces errors. However, challenges such as maintaining compliance, ensuring data security, and managing complex lifecycle updates remain. This paper explores the integration of blockchain technology into eCTD submissions as a solution to these issues. Blockchain’s decentralized and immutable structure enhances data integrity, transparency, and tamper resistance. Smart contracts can automate compliance checks, reduce manual intervention, and improve process efficiency. Additionally, combining blockchain with technologies like artificial intelligence and cloud computing enables real-time data sharing, predictive analytics, and enhanced decision-making. These innovations can lead to faster regulatory reviews and improved stakeholder trust. For successful adoption, blockchain must be harmonized with existing regulatory systems through interoperable platforms and collaborative efforts among regulatory bodies, pharmaceutical companies, and technology providers. This paper highlights how blockchain can transform eCTD submissions by increasing operational efficiency, enhancing data security, and fostering transparent, streamlined regulatory processes.

Loading

Article metrics loading...

/content/journals/adctra/10.2174/0126673371393590250801040734
2025-08-05
2025-10-27
Loading full text...

Full text loading...

/deliver/fulltext/adctra/11/1/ADCTRA-11-E26673371393590.html?itemId=/content/journals/adctra/10.2174/0126673371393590250801040734&mimeType=html&fmt=ahah

References

  1. KhristiA.P. GuptaV. Regulatory approval and challenges in the digital era. In: Converging Pharmacy Science and Engineering in Computational Drug Discovery.IGI Global202427028610.4018/979‑8‑3693‑2897‑2.ch014
    [Google Scholar]
  2. ChongS.S.F. OngS.H.M. LongS.M. Advancements in regulatory agility, regional collaboration, and digital transformation: Insights from the Asia Partnership Conference of Pharmaceutical Associations (APAC).AAPS Open20241011410.1186/s41120‑024‑00102‑2
    [Google Scholar]
  3. NagareV.R. A review on regulatory affairs in pharmaceutical industry.Int J Pharm Life Sci2025163
    [Google Scholar]
  4. ChenL. DombrowskyE. BoyleB. TangC. ThanneerN. PmWebSpec: An application to create and manage cdisc-compliant pharmacometric analysis dataset specifications.AAPS J.20242633910.1208/s12248‑024‑00910‑0 38570385
    [Google Scholar]
  5. ParryG.M. Blockchain technology: Enabling decentralized and secure industrial processes in industry 5.0. In: Industry 50 and Emerging Technologies: Transformation Through Technology and Innovations.Springer2024259296
    [Google Scholar]
  6. AryaL. Securing Healthcare Data and Cybersecurity Innovations in the Era of Industry 5.0. In: Cybersecurity and Data Management Innovations for Revolutionizing Healthcare.IGI Global202413214710.4018/979‑8‑3693‑7457‑3.ch006
    [Google Scholar]
  7. SchneikartG. MayrhoferW. LöfflerC. FrysakJ. A roadmap towards circular economies in pharma logistics based on returnable transport items enhanced with Industry 4.0 technologies.Resour. Conserv. Recycling202420610761510.1016/j.resconrec.2024.107615
    [Google Scholar]
  8. ArbitH.M. TeepleW. New drug application. In: Navigating the FDA Regulatory Processes.CRC Press2025185410.1201/9781315117911‑3
    [Google Scholar]
  9. ParameshaM. RaneN. RaneJ. Big data analytics, artificial intelligence, machine learning, internet of things, and blockchain for enhanced business intelligence.SSRN2024121103310.2139/ssrn.4855856
    [Google Scholar]
  10. TalwandiN.S. KhareS. ThakurP. Revolutionizing pharmaceuticals: Harnessing blockchain for industry solutions. In: Blockchain‐Enabled Solutions for the Pharmaceutical Industry.Wiley2025194010.1002/9781394287970.ch2
    [Google Scholar]
  11. Electronic common technical document (eCTD) v4.02024Available from: https://www.fda.gov/drugs/electronic-regulatory-submission-and-review/electronic-common-technical-document-ectd-v40
  12. Human submission eCTD V3.2 eCTD EU M1 specification.Available from: https://esubmission.ema.europa.eu/
  13. Swiss agency for therapeutic products (Swissmedic).Available from: https://www.swissmedic.ch
  14. South African health products regulatory authority (SAHPRA).Available from: https://www.sahpra.org.za
  15. Brazilian health regulatory agency (ANVISA)Available from: https://www.gov.br/anvisa/
  16. National medical products administration (NMPA), China.Available from: https://www.cde.org.cn
  17. Therapeutic goods administration (TGA), Australia.Available from: https://www.tga.gov.au
  18. Central drugs standard control organization (CDSCO), India.Available from: https://cdsco.gov.in
  19. Pharmaceuticals and medical devices agency (PMDA), Japan.Available from: https://www.pmda.go.jp/english/
  20. International council for harmonisation of technical requirements for pharmaceuticals for human use (ICH). Electronic common technical document (eCTD).Available from: https://www.ich.org/page/electronic-common-technical-document-ectd
  21. Health Canada.Drug submission and review process.Available from: https://www.canada.ca/en/health-canada/services.html
    [Google Scholar]
/content/journals/adctra/10.2174/0126673371393590250801040734
Loading
/content/journals/adctra/10.2174/0126673371393590250801040734
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test